CHI Advisors’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$207K Sell
20,221
-33,231
-62% -$511K 0.08% 26
2023
Q2
$843K Sell
53,452
-62,209
-54% -$1.42M 0.26% 21
2023
Q1
$2.61M Sell
115,661
-2,666
-2% -$87.8K 0.69% 16
2022
Q4
$4.22M Sell
118,327
-4,167
-3% -$165K 1.13% 13
2022
Q3
$4.78M Buy
122,494
+22,369
+22% +$1.06M 1.28% 14
2022
Q2
$4.81M Buy
100,125
+79,904
+395% +$4.69M 1.84% 11
2022
Q1
$1.87M Hold
20,221
0.79% 21
2021
Q4
$4.49M Sell
20,221
-1,337
-6% -$373K 1.49% 15
2021
Q3
$7.46M Sell
21,558
-166
-0.8% -$56.3K 2.18% 12
2021
Q2
$8.16M Sell
21,724
-1,330
-6% -$399K 1.9% 13
2021
Q1
$7.16M Sell
23,054
-5,358
-19% -$1.88M 1.43% 13
2020
Q4
$7.11M Sell
28,412
-5,416
-16% -$1.33M 2% 10
2020
Q3
$6.25M Buy
33,828
+1,827
+6% +$363K 2.22% 10
2020
Q2
$8M Buy
32,001
+649
+2% +$142K 3.12% 7
2020
Q1
$5.67M Buy
31,352
+1,940
+7% +$508K 13.37% 2
2019
Q4
$12.3M Sell
29,412
-6,714
-19% -$2.11M 9.24% 3
2019
Q3
$9.09M Buy
+36,126
New +$11.8M 8.85% 3

Other funds holding DTIL

CHI Advisors's DTIL Position: Q3 2023 in Review

CHI Advisors reduced its Precision BioSciences (DTIL) stake by 62% in Q3 2023, selling an estimated $511K and leaving 20,221 shares worth $207K. The position accounts for 0.08% of the portfolio, ranked #26.

CHI Advisors first reported a position in DTIL in Q3 2019 and has held it in 17 quarters since. The position peaked at $12.3M in Q4 2019. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

  • CHI Advisors held 20,221 shares of Precision BioSciences worth $207K as of Q3 2023.
  • CHI Advisors sold 33,231 Precision BioSciences shares in Q3 2023, an estimated $511K.
  • Precision BioSciences made up 0.08% of CHI Advisors's portfolio in Q3 2023, its #26 holding.
  • CHI Advisors first reported a position in Precision BioSciences in Q3 2019 and has held it in 17 quarters since.
  • CHI Advisors's Precision BioSciences position peaked at $12.3M in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.